Figure 4.

Characteristics of patients with and without MLF after glucocorticoid therapy. (A) Cumulative oral prednisolone dosage. (B) Cumulative oral prednisolone dosage corrected for body weight. (C) Sum of facial measurements. (D) Δ Sum of facial measurements. (E) Body weight at the end of the observation period. (F) Δ Body weight. (A) Score of the BILSv1.2. We excluded 10 patients who did not provide informed consent. The results were compared between the lowest scores. (C, D) Results were compared at the time of MLF determination for patients with MLF and at the end of the observation period for those without MLF. Abbreviations: BILSv1.2, Bilateral Inverted Locus of the Skin; MLF, moon-like facies.